BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 26324099)

  • 1. Midlife adiposity predicts earlier onset of Alzheimer's dementia, neuropathology and presymptomatic cerebral amyloid accumulation.
    Chuang YF; An Y; Bilgel M; Wong DF; Troncoso JC; O'Brien RJ; Breitner JC; Ferruci L; Resnick SM; Thambisetty M
    Mol Psychiatry; 2016 Jul; 21(7):910-5. PubMed ID: 26324099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Contribution of Cerebral Vascular Neuropathology to Mild Stage of Alzheimer's Dementia Using the NACC Database.
    Liu Y; Chan DK; Crawford JD; Sachdev PS; Braidy N
    Curr Alzheimer Res; 2020; 17(13):1167-1176. PubMed ID: 33583381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages.
    Pascoal TA; Benedet AL; Tudorascu DL; Therriault J; Mathotaarachchi S; Savard M; Lussier FZ; Tissot C; Chamoun M; Kang MS; Stevenson J; Massarweh G; Guiot MC; Soucy JP; Gauthier S; Rosa-Neto P
    Brain; 2021 Dec; 144(11):3517-3528. PubMed ID: 34515754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis.
    Irwin DJ; Grossman M; Weintraub D; Hurtig HI; Duda JE; Xie SX; Lee EB; Van Deerlin VM; Lopez OL; Kofler JK; Nelson PT; Jicha GA; Woltjer R; Quinn JF; Kaye J; Leverenz JB; Tsuang D; Longfellow K; Yearout D; Kukull W; Keene CD; Montine TJ; Zabetian CP; Trojanowski JQ
    Lancet Neurol; 2017 Jan; 16(1):55-65. PubMed ID: 27979356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.
    Monsell SE; Kukull WA; Roher AE; Maarouf CL; Serrano G; Beach TG; Caselli RJ; Montine TJ; Reiman EM
    JAMA Neurol; 2015 Oct; 72(10):1124-31. PubMed ID: 26302353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroimaging correlates with neuropathologic schemes in neurodegenerative disease.
    Lowe VJ; Lundt ES; Albertson SM; Przybelski SA; Senjem ML; Parisi JE; Kantarci K; Boeve B; Jones DT; Knopman D; Jack CR; Dickson DW; Petersen RC; Murray ME
    Alzheimers Dement; 2019 Jul; 15(7):927-939. PubMed ID: 31175025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer diagnosis is associated with a lower burden of dementia and less Alzheimer's-type neuropathology.
    Karanth SD; Katsumata Y; Nelson PT; Fardo DW; McDowell JK; Schmitt FA; Kryscio RJ; Browning SR; Braithwaite D; Arnold SM; Abner EL
    Brain; 2022 Jul; 145(7):2518-2527. PubMed ID: 35094057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.
    Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM
    Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease.
    Kadir A; Marutle A; Gonzalez D; Schöll M; Almkvist O; Mousavi M; Mustafiz T; Darreh-Shori T; Nennesmo I; Nordberg A
    Brain; 2011 Jan; 134(Pt 1):301-17. PubMed ID: 21149866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropathology of Alzheimer's disease: a critical update.
    Jellinger KA; Bancher C
    J Neural Transm Suppl; 1998; 54():77-95. PubMed ID: 9850917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex-Specific Association of Lifetime Body Mass Index with Alzheimer's Disease Neuroimaging Biomarkers.
    Lee SH; Byun MS; Lee JH; Yi D; Sohn BK; Lee JY; Kim YK; Shin SA; Sohn CH; Lee DY;
    J Alzheimers Dis; 2020; 75(3):767-777. PubMed ID: 32333586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Midlife blood pressure, plasma β-amyloid, and the risk for Alzheimer disease: the Honolulu Asia Aging Study.
    Shah NS; Vidal JS; Masaki K; Petrovitch H; Ross GW; Tilley C; DeMattos RB; Tracy RP; White LR; Launer LJ
    Hypertension; 2012 Apr; 59(4):780-6. PubMed ID: 22392902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau.
    Hohman TJ; Dumitrescu L; Barnes LL; Thambisetty M; Beecham G; Kunkle B; Gifford KA; Bush WS; Chibnik LB; Mukherjee S; De Jager PL; Kukull W; Crane PK; Resnick SM; Keene CD; Montine TJ; Schellenberg GD; Haines JL; Zetterberg H; Blennow K; Larson EB; Johnson SC; Albert M; Bennett DA; Schneider JA; Jefferson AL;
    JAMA Neurol; 2018 Aug; 75(8):989-998. PubMed ID: 29801024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer disease pathology and longitudinal cognitive performance in the oldest-old with no dementia.
    Balasubramanian AB; Kawas CH; Peltz CB; Brookmeyer R; Corrada MM
    Neurology; 2012 Aug; 79(9):915-21. PubMed ID: 22895581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology.
    Perez-Nievas BG; Stein TD; Tai HC; Dols-Icardo O; Scotton TC; Barroeta-Espar I; Fernandez-Carballo L; de Munain EL; Perez J; Marquie M; Serrano-Pozo A; Frosch MP; Lowe V; Parisi JE; Petersen RC; Ikonomovic MD; López OL; Klunk W; Hyman BT; Gómez-Isla T
    Brain; 2013 Aug; 136(Pt 8):2510-26. PubMed ID: 23824488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resilience and resistance to the accumulation of amyloid plaques and neurofibrillary tangles in centenarians: An age-continuous perspective.
    Zhang M; Ganz AB; Rohde S; Rozemuller AJM; Bank NB; Reinders MJT; Scheltens P; Hulsman M; Hoozemans JJM; Holstege H
    Alzheimers Dement; 2023 Jul; 19(7):2831-2841. PubMed ID: 36583547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age, Alzheimer's disease and dementia in the Baltimore Longitudinal Study of Ageing.
    Dolan D; Troncoso J; Resnick SM; Crain BJ; Zonderman AB; O'Brien RJ
    Brain; 2010 Aug; 133(Pt 8):2225-31. PubMed ID: 20647264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer's disease spectrum.
    Murray ME; Lowe VJ; Graff-Radford NR; Liesinger AM; Cannon A; Przybelski SA; Rawal B; Parisi JE; Petersen RC; Kantarci K; Ross OA; Duara R; Knopman DS; Jack CR; Dickson DW
    Brain; 2015 May; 138(Pt 5):1370-81. PubMed ID: 25805643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced Glycation End Product Formation in Human Cerebral Cortex Increases With Alzheimer-Type Neuropathologic Changes but Is Not Independently Associated With Dementia in a Population-Derived Aging Brain Cohort.
    Chambers A; Bury JJ; Minett T; Richardson CD; Brayne C; Ince PG; Shaw PJ; Garwood CJ; Heath PR; Simpson JE; Matthews FE; Wharton SB
    J Neuropathol Exp Neurol; 2020 Sep; 79(9):950-958. PubMed ID: 32766675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correspondence between in vivo (11)C-PiB-PET amyloid imaging and postmortem, region-matched assessment of plaques.
    Driscoll I; Troncoso JC; Rudow G; Sojkova J; Pletnikova O; Zhou Y; Kraut MA; Ferrucci L; Mathis CA; Klunk WE; O'Brien RJ; Davatzikos C; Wong DF; Resnick SM
    Acta Neuropathol; 2012 Dec; 124(6):823-31. PubMed ID: 22864813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.